| Execution period | 12 months |
|---|
NSE filing, NSE: NUVAMA. Summary written from the filing by ALFA Finder's alert engine.
Nuvama Wealth Management Ltd: key numbers
- Share price
- ₹1,873.40
- Market cap
- ₹34,574 Cr
- Revenue (annual)
- ₹4,631 Cr
- Net profit (annual)
- ₹1,041 Cr
- P/E (TTM)
- 31.9×Sector 20.3×
- Promoter holding
- 53.40%-0.58% QoQ
- FII holding
- 19.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nuvama Wealth Management Ltd
All →Nuvama Wealth Management Share Pledge
Catalyst Trusteeship discloses a new pledge of 3.51 crore Nuvama shares by PAG Ecstasy. Total encumbered shares rise to 9.70 crore, securing a USD 450 million facility.
- Value
- ₹4,230 Cr
Nuvama Wealth Management Share Pledge
Promoter PAGAC Ecstasy pledged 3,50,74,460 additional NWML shares for overseas borrowings. Total encumbered shares now stand at 9,69,60,340 (52.54%).
Nuvama Wealth Management Employee Stock Options
Nuvama Wealth Management allotted 33,912 equity shares upon ESOP/ESAR exercise. Post-allotment, paid-up capital increased to 18,45,49,601 shares of ₹2 face value.
Nuvama Wealth Management Board Meeting Date
Nuvama Wealth will hold a board meeting on 6 November 2026 to consider Q2 and H1 results. An earnings call follows on 9 November.
Nuvama Wealth Management Regulatory Approval
Nuvama Asset Management, a subsidiary of the company, received SEBI approval to establish a Specialized Investment Fund, enabling the launch of its Numa SIF platform.
Nuvama Wealth Management Price Movement Clarification
Nuvama Wealth Management replied to a BSE volume-movement surveillance query. The company confirmed no undisclosed event or UPSI exists requiring Regulation 30 disclosure.
Other management change announcements
All →Ceat Management Change
CEAT Limited has issued a postal ballot notice seeking shareholder approval to appoint Mr. Sumeet Narang as a Non-Executive Independent Director. E-voting runs 7 Nov to 6 Dec 2026.
Sai Life Science Management Change
Sai Life Sciences appointed three senior management personnel effective 5 November 2026. The appointees include Sidhartha Das as Senior Vice President and Head of Human Resources.
Karamtara Engineering Management Change
Karamtara Engineering appointed Ajoy Mehta and Sanjeeb Chaudhuri as Non-Executive Independent Directors effective November 5, 2026. Each appointment is for a 60-month term.
- Execution
- 60 months
Nimbus Projects Management Change
Nimbus Projects Ltd's Chairman Bipin Agarwal is stepping down from the Chairman role effective November 5, 2026, while remaining Managing Director. No change to his directorship, MD role or remuneration.
Shyam Century Ferrous Management Change
Shyam Century Ferrous's Company Secretary Ritu Agarwal resigned, effective November 30, 2026, citing personal reasons. The resignation letter was received October 16, 2026.
Kalpataru Projects International Management Change
Kalpataru Projects approved the appointment of Amit Uplenchwar as Joint Managing Director and CEO, effective January 1, 2027. The five-year term is subject to shareholder approval.
- Execution
- January 1, 2027 to December 31, 2031